Jump to content


  • Content count

  • Joined

  • Last visited

  • Country

    United States

About MOBB

  • Rank
    Advanced Member

Profile Information

  • Gender
    Not Telling
  • Occupation
    blood banker
  1. Analyzer updates?

    We went live on our Erytra over a year ago. We're very happy with the analyzer and I love working with grifols.
  2. This is a real issue for us lately. Medical staff toss the units in the stretcher with the patient and off they go. More often than not, we're not told the patient was transferred and if the units are transfused. Or we get a call from the other hospital telling us the unit(s) were disposed. We keep educating...
  3. They didn't discuss any of the transfusion medicine changes, only said there were many updates. It was a pretty big waste of time. I don't know if they recorded it.
  4. So in a follow up conversation with Amy from CAP, she said CAP was working to revise the wording next year to clarify that unresolved/unexpected ABO discrepancies require a serologic crossmatch. Resolved issues are not disqualified. I called again today to get clarification on many of the revisions and I was told that CAP does not define an ABO discrepancy and if my policy defines an ABO discrepancy as one that is unresolved/unexpected we can carry on with business as usual.
  5. I don't know if she's a blood banker, but she was the CAP employee I was transferred to for the transfusion med checklist...I would hope that means she's a blood banker
  6. Massive Transfusion Protocol

    All of our hospitals have an MTP protocol. The beauty of the protocol is it helps eliminate any roadblocks that might slow down product getting to the patient. Also it removes guesswork for the clinical staff. Too many times they freak out and keep ordering RBCs and forget about balancing FFP.
  7. RBC Inventory Practices

    We keep 4 days worth of blood on our shelves. Our blood supplier looks at our last 6 months of transfusions and works with us to set par levels to ensure we have the 4 days of blood and are not returning too many RBCs due to short dates.
  8. How is everyone feeling about pathogen reduced platelets and pediatric patients? I have yet to see a study done in the US. For those outside the US, have you seen any adverse effects from transfusing pathogen reduced products to pediatric patients? Has anyone seen issues with patients allergic to celery, limes, figs or other foods that contain psoralens?
  9. 2rd determination of recipient's ABO

    We never retest the same sample. If we don't have a second sample we crossmatch group O neg. We require a second type to switch blood groups and rh. In an emergency, we'll switch to rh pos for adult males or women >55.
  10. Malcom, We have a similar practice for babies under 4 months but require crossmatches starting at 4 months, yet many of the babies (especially premies) don't back type until 12 months or even later. Computer crossmatches were a huge help for this population so I'm sad to see this change, especially since we only transfuse group O products to them-they'll be MF and no reverse type! It would make more sense if we were crossmatching all groups for this population...
  11. I'm looking forward to the seminar. I'm also curious about the missing serum reactivity. Will this eliminate babies where there is no expected serum reactivity Malcom, How does the UK handle computer crossmatches and missing serum reactivity? Are computer crossmatches allowed for babies with no reverse type? I remember you stating at one point that our accredditing friends from the US and UK were comparing notes and picking the stricter ones from each side of the pond?
  12. I completely agree. However, Amy from CAP did not.
  13. That's why I was confused and asked more than once to verify. The majority of our MF patients have received blood from us and have a history of multiple types. The only thing I can think is to prevent hospitals from not really resolving a MF and just assuming an O or rh neg transfusion is causing the MF.
  14. The 2017 revisions were released this week. The computer crossmatch section was revised to align with the FDA guidance. "If ABO typing discrepancies exist, you should not rely on a computer crossmatch.This is particularly important if there is mixed field red cell reactivity, missing serum reactivity, or apparent change in blood type following hematopoietic stem cell transplantation.Under those circumstances, your procedures should provide for compatibility testing using serologic crossmatch techniques." I called CAP to verify that this included resolved ABO discrepancies. Our hospital had been allowing computer crossmatches for ABO discrepancies that are resolved, and I'm not sure that our BB LIS could prevent a patient with a resolved ABO discrepancy from receiving a computer crossmatch. Does your LIS prevent computer crossmatches for patients with MF reactions or weak reverses?